Dr. D. Prabhakaran, MD, DM, MSc
The burden of chronic diseases has reached epidemic proportion in India along with the penitence of preternatural diseases. It is now experiencing a polarized and protracted double burden of disease. In India, there are 65 million people living with diabetes and the annual coronary deaths are expected to reach 4 million in 2030. At the present stage of India’s health transition, chronic diseases contribute to an estimated 53% of deaths and 44% of disability-adjusted life-years lost. Cardiovascular diseases and diabetes are highly prevalent in urban areas. Tobacco related cancers account for a large proportion of all cancers. Tobacco consumption, in diverse smoked and smokeless forms, is common, especially among the poor and rural population segments. Hypertension and dyslipidaemia, although common, are inadequately detected and treated. Demographic and socioeconomic factors are hastening the health transition, with sharp escalation of chronic disease burdens expected over the next 20 years. Despite this broad knowledge, the biomedical research community faces formidable challenges in understanding the dynamics, determinants and dimension of chronic diseases.
The chronic care paradigm encompasses preventive and therapeutic care, and both must incorporate risk-factor management. The quest requires here a shared vision that echoes to address the serious problem: to serve society; to foster generalist and decrease fragmentation; to address the changing nature of illness and the changing nature of practice. We need carefully designed, comprehensive, nationally important chronic diseases policies and carry out relevant research and develop evidence based guidelines, which leave ample room for local adaptation and the full engagement of local communities and create an important basis to realize the full potential of research, training, policy development and advocacy program for chronic diseases.
For a decade, CCDC has conducted various researches and studies to know the cause of these chronic diseases and has come out with many solutions to control and prevent chronic diseases which are evident in its track record on high impact publications.
We are optimistic that there will always be support for innovative science that has the potential to improve human health. CCDC will continue with the spirit of innovation in providing cost-effective solutions through research. This we believe will result in CCDC emerging as a major force in chronic disease prevention.
Biography of the Director
Prof. D. Prabhakaran, MD, DM (Cardiology), MSc, FRCP, FNASc.
Centre for Chronic Disease Control (CCDC)
Director – Center for Control of Chronic Conditions (CCCC)
Vice President – Public Health Foundation of India (PHFI)
Professor, Department of Epidemiology – London School of Hygiene and Tropical Medicine, London, UK
Adjunct Professor – Rollins School of Public Health, Emory University
Professor D. Prabhakaran is a cardiologist and epidemiologist by training. He is an internationally renowned researcher. His research work spans from mechanistic research to understanding the causes for increased propensity of cardiovascular diseases (CVD) among Indians, to developing solutions for CVD risk reduction through translational research. Prof. Prabhakaran is a Fellow of the Royal College of Physicians, UK, Fellow of the National Academy of Sciences, India, a part time Professor at the London School of Hygiene and Tropical Medicine and an Adjunct Professorship at the Emory University. He is a member of the executive council of the International Society of Hypertension (ISH) and the International Society of CVD Epidemiology and Prevention (ISCEP). He has received funding from NHLBI, Wellcome Trust, European Commission and several other international and national funding bodies. He has mentored over 30 post-doctoral and doctoral students so far. He has authored several chapters and over 250 scholarly papers with an H-index of 41 and over 16000 citations. He is the lead editor of the Cardiovascular Disease volume of the latest Disease Control Priorities Project.